190
Views
1
CrossRef citations to date
0
Altmetric
Review Articles

The incidence and prevalence of unruptured intracranial aneurysms in sickle cell disease patients: a systematic review

, &
Pages 669-677 | Received 23 Mar 2022, Accepted 08 Jul 2022, Published online: 08 Aug 2022

References

  • Brown RD, Broderick JP. Unruptured intracranial aneurysms: epidemiology, natural history, management options, and familial screening. Lancet Neurol 2014;13:393–404.
  • Lee KS, Zhang JJY, Alalade AF, et al. Radiological surveillance of small unruptured intracranial aneurysms: a systematic review, meta-analysis, and meta-regression of 8428 aneurysms. Neurosurg Rev 2021;44:2013–23.
  • Wermer MJ, Van Der Schaaf IC, Algra A, Rinkel GJ. Risk of rupture of unruptured intracranial aneurysms in relation to patient and aneurysm characteristics: an updated meta-analysis. Stroke 2007;38:1404–10.
  • Chapman IYKAA. Intracranial aneurysms in ADPKD how far have we come? Clin J Am Soc Nephrol 2019;14:1119–21.
  • Vlak MH, Rinkel GJ, Greebe P, Algra A. Independent risk factors for intracranial aneurysms and their joint effect: a case-control study. Stroke 2013;44:984–7.
  • Brandao R, De Carvalho GTC, Reis BL, Bahia E, De Souza AA. Intracranial aneurysms in sickle cell patients: report of 2 cases and review of the literature. Surg Neurol 2009;72:296–9.
  • Oyesiku NM, Barrow DL, Eckman JR, Tindall SC, Colohan AR. Intracranial aneurysms in sickle-cell anemia: clinical features and pathogenesis. J Neurosurg 1991;75:356–63.
  • Raaymakers TW, Rinkel GJ, Limburg M, Algra A. Mortality and morbidity of surgery for unruptured intracranial aneurysms: a meta-analysis. Stroke 1998;29:1531–8.
  • Korja M, Silventoinen K, Laatikainen T, Jousilahti P, Salomaa V, Kaprio J. Cause-specific mortality of 1-year survivors of subarachnoid hemorrhage. Neurology 2013;80:481–6.
  • Griffiths PD, Worthy S, Gholkar A. Incidental intracranial vascular pathology in patients investigated for carotid stenosis. Neuroradiology 1996;38:25–30.
  • Juvela, S. Scoring of growth of unruptured intracranial aneurysms. Journal of clinical medicine 2020;9(10):3339.
  • International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms—risk of rupture and risks of surgical intervention. New Eng J Med 1998;339:1725–33.
  • Wiebers DO, Whisnant JP, Huston J 3RD, et al. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet 2003;362:103–10.
  • Birkeland P, Gardner K, Kesse-Adu R, et al. Intracranial aneurysms in sickle-cell disease are associated with the hemoglobin SS genotype but not with moyamoya syndrome. Stroke 2016;47:1710–3.
  • Greving JP, Wermer MJ, Brown Jr RD, et al. Development of the PHASES score for prediction of risk of rupture of intracranial aneurysms: a pooled analysis of six prospective cohort studies. Lancet Neurol 2014;13:59–66.
  • Bijlenga P, Gondar R, Schilling S, et al. PHASES score for the management of intracranial aneurysm: a cross-sectional population-based retrospective study. Stroke 2017;48:2105–12.
  • Etminan N, Beseoglu K, Barrow DL, et al. Multidisciplinary consensus on assessment of unruptured intracranial aneurysms: proposal of an international research group. Stroke 2014;45:1523–30.
  • Brinjikji W, Zhu YQ, Lanzino G, et al. Risk factors for growth of intracranial aneurysms: a systematic review and meta-analysis. AJNR Am J Neuroradiol 2016;37:615–20.
  • Juvela S. Growth and rupture of unruptured intracranial aneurysms. J Neurosurg 2018;131:843–51.
  • Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLOS Med 2009;6:e1000097.
  • Moher D, Pham B, Lawson M, Klassen T. The inclusion of reports of randomised trials published in languages other than English in systematic reviews. Health Technol Assess 2003;7:1–90.
  • Morrison A, Polisena J, Husereau D, et al. The effect of English-language restriction on systematic review-based meta-analyses: a systematic review of empirical studies. Int J Technol Assess Health Care 2012;28:138–44.
  • Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg 2003;73:712–6.
  • Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schünemann HJ. What is “quality of evidence” and why is it important to clinicians? BMJ 2008;336:995–8.
  • Bisson D-A, Amirabadi A, Shroff MM, et al. Unruptured intracranial aneurysms in children: 18 years' experience in a tertiary care pediatric institution. J Neurosurg Pediatrics 2019;24:184–9.
  • Anson JA, Koshy M, Ferguson L, Crowell RM. Subarachnoid hemorrhage in sickle-cell disease. J Neurosurg 1991;75:552–8.
  • Gaudre N, Michelozzi C, Kamsu MJ, Cougoul P, Nasr N. Increased prevalence of cerebral aneurysms in adult patients with sickle cell disease. Eur Stroke J 2017;2:396.
  • Anson JA, Koshy M, Ferguson L, Crowell RM. Subarachnoid hemorrhage in sickle-cell disease. J Neurosurg 1991a;75:552–8.
  • Birkeland P, Gardner K, Kesse-Adu R, et al. Intracranial aneurysms in sickle-cell disease are associated with the hemoglobin SS genotype but not with moyamoya syndrome. Stroke 2016;47:1710–3.
  • Gallas S, Tuilier T, Ebrahiminia V, Bartolucci P, Hodel J, Gaston A. Intracranial aneurysms in sickle cell disease: aneurysms characteristics and modalities of endovascular approach to treat these patients. J Neuroradiol 2020a;47:221–6.
  • Gross BA, Smith ER, Scott RM, Orbach DB. Intracranial aneurysms in the youngest patients: characteristics and treatment challenges. Pediatr Neurosurg 2014;50:8.
  • Kassim AA, Pruthi S, Day M, et al. Silent cerebral infarcts and cerebral aneurysms are prevalent in adults with sickle cell anemia. Blood 2016a;127:2038–40.
  • Kossorotoff M, Brousse V, Grevent D, et al. Cerebral haemorrhagic risk in children with sickle-cell disease. Dev Med Child Neurol 2015;57:187–93.
  • Kuril S, Johnson M, Kanter J. Incidental unruptured intracranial aneurysms in selected population of sickle cell disease: an institutional experience. Pediatr Blood Cancer 2016;63:S48–S48.
  • Nabavizadeh SA, Vossough A, Ichord RN, et al. Intracranial aneurysms in sickle cell anemia: clinical and imaging findings. J Neurointerv Surg 2016;8:434–40.
  • Saini S, Speller-Brown B, Wyse E, et al. Unruptured intracranial aneurysms in children with sickle cell disease: analysis of 18 aneurysms in 5 patients. Neurosurgery 2015;76:531–9.
  • Kossorotoff M, Brousse V, Grevent D, et al. Cerebral haemorrhagic risk in children with sickle-cell disease. Dev Med Child Neurol 2015;57:187–93.
  • Saini S, Speller-Brown B, Wyse E, et al. Unruptured intracranial aneurysms in children with sickle cell disease: analysis of 18 aneurysms in 5 patients. Neurosurgery 2015;76:531–9.
  • Gross BA, Smith ER, Scott RM, Orbach DB. Intracranial aneurysms in the youngest patients: characteristics and treatment challenges. Pediatric Neurosurg 2014;50:8.
  • Gallas S, Tuilier T, Ebrahiminia V, Bartolucci P, Hodel J, Gaston A. Intracranial aneurysms in sickle cell disease: aneurysms characteristics and modalities of endovascular approach to treat these patients. J Neuroradiol 2020;47:221–6.
  • Kassim AA, Pruthi S, Day M, et al. Silent cerebral infarcts and cerebral aneurysms are prevalent in adults with sickle cell anemia. Blood 2016;127:2038–40.
  • Kuril S, Johnson M, Kanter J. Incidental unruptured intracranial aneurysms in selected population of sickle cell disease: an institutional experience. Pediatric Blood Cancer 2016;63:S48–S48.
  • Asaithambi G, Adil MM, Chaudhry SA, Qureshi AI. Incidences of unruptured intracranial aneurysms and subarachnoid hemorrhage: results of a statewide study. J Vasc Interv Neurol 2014;7:14–7.
  • Woodworth GF, Baird CJ, Garces-Ambrossi G, Tonascia J, Tamargo RJ. Inaccuracy of the administrative database: comparative analysis of two databases for the diagnosis and treatment of intracranial aneurysms. Neurosurgery 2009;65:251–6. discussion 256–7.
  • Biswas T. Global burden of sickle cell anaemia is set to rise by a third by 2050. BMJ 2013;347:f4676.
  • Vlak MH, Algra A, Brandenburg R, Rinkel GJ. Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis. Lancet Neurol 2011;10:626–36.
  • Cagnazzo F, Gambacciani C, Morganti R, Perrini P. Intracranial aneurysms in patients with autosomal dominant polycystic kidney disease: prevalence, risk of rupture, and management. A systematic review. Acta Neurochir 2017;159:811–21.
  • Hurford R, Taveira I, Kuker W, Rothwell PM. Prevalence, predictors and prognosis of incidental intracranial aneurysms in patients with suspected TIA and minor stroke: a population-based study and systematic review. J Neurol Neurosurg Psychiatry 2021;92:542–8.
  • Lubeck D, Agodoa I, Bhakta N, et al. Estimated life expectancy and income of patients with sickle cell disease compared with those without sickle cell disease. JAMA Netw Open 2019;2:e1915374–e1915374.
  • Korja M, Kivisaari R, Rezai Jahromi B, Lehto H. Size and location of ruptured intracranial aneurysms: consecutive series of 1993 hospital-admitted patients. J Neurosurg 2017;127:748–53.
  • Diggs LW, Brookoff D. Multiple cerebral aneurysms in patients with sickle cell disease. South Med J 1993;86:377–9.
  • Preul M, Cendes F, Just N, Mohr G. Intracranial aneurysms and sickle cell anemia: multiplicity and propensity for the vertebrobasilar territory. Neurosurgery 1998;42:971–7.
  • Williams LN, Brown RD JR. Management of unruptured intracranial aneurysms. Neurol Clin Pract 2013;3:99–108.
  • Overby MC, Rothman AS. Multiple intracranial aneurysms in sickle cell anemia: report of two cases. J Neurosurg 1985;62:430–4.
  • Kassell NF, Torner JC. Size of intracranial aneurysms. Neurosurgery 1983;12:291–7.
  • Cras TY, Bos D, Ikram MA, et al. Determinants of the presence and size of intracranial aneurysms in the general population: the Rotterdam study. Stroke 2020;51:2103–10.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.